The c.-1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients

The c.-1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients

Item
http://www.wikidata.org/entity/Q28306899
Novel microtubule-targeted agent 6-chloro-4-(methoxyphenyl) coumarin induces G2-M arrest and apoptosis in HeLa cells.Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population.VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation.Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement.Use of genetic and nongenetic factors in warfarin dosing algorithms.Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.Pharmacogenetics guided anticoagulation.Pharmacogenetics aspects of oral anticoagulants therapy.Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations.An acenocoumarol dose algorithm based on a South-Eastern European population.A genome-wide association study of acenocoumarol maintenance dosage.Pharmacogenetic impact of VKORC1 and CYP2C9 allelic variants on warfarin dose requirements in a hispanic population isolate.VKORC1 and CYP2C9 allelic variants influence acenocoumarol dose requirements in Greek patients.Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.Dietary reference values for vitamin KInfluence of CYP2C9 and VKORC1 polymorphisms on warfarin and acenocoumarol in a sample of Lebanese people.
P2860

The c.-1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients

Item
http://www.wikidata.org/entity/Q28306899
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The c.-1639G > A polymorphism ...... rol in anticoagulated patients
@ast
The c.-1639G > A polymorphism ...... rol in anticoagulated patients
@en
The c.-1639G > A polymorphism ...... rol in anticoagulated patients
@nl
type
label
The c.-1639G > A polymorphism ...... rol in anticoagulated patients
@ast
The c.-1639G > A polymorphism ...... rol in anticoagulated patients
@en
The c.-1639G > A polymorphism ...... rol in anticoagulated patients
@nl
prefLabel
The c.-1639G > A polymorphism ...... rol in anticoagulated patients
@ast
The c.-1639G > A polymorphism ...... rol in anticoagulated patients
@en
The c.-1639G > A polymorphism ...... rol in anticoagulated patients
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
The c.-1639G > A polymorphism ...... rol in anticoagulated patients
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2141.2006.06007.X
P407
P433
P478
P50
P577
P5875
P698